These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 26215151)
1. Complement factor H R1210C among Japanese patients with age-related macular degeneration. Miyake M; Saito M; Yamashiro K; Sekiryu T; Yoshimura N Jpn J Ophthalmol; 2015 Sep; 59(5):273-8. PubMed ID: 26215151 [TBL] [Abstract][Full Text] [Related]
2. Phenotype and genotype characteristics of age-related macular degeneration in a Japanese population. Mori K; Horie-Inoue K; Gehlbach PL; Takita H; Kabasawa S; Kawasaki I; Ohkubo T; Kurihara S; Iizuka H; Miyashita Y; Katayama S; Awata T; Yoneya S; Inoue S Ophthalmology; 2010 May; 117(5):928-38. PubMed ID: 20132989 [TBL] [Abstract][Full Text] [Related]
3. Single-Nucleotide Polymorphisms Associated With Age-Related Macular Degeneration and Lesion Phenotypes in the Comparison of Age-Related Macular Degeneration Treatments Trials. Maguire MG; Ying GS; Jaffe GJ; Toth CA; Daniel E; Grunwald J; Martin DF; Hagstrom SA; JAMA Ophthalmol; 2016 Jun; 134(6):674-81. PubMed ID: 27099955 [TBL] [Abstract][Full Text] [Related]
4. Phenotypic Characterization of Complement Factor H R1210C Rare Genetic Variant in Age-Related Macular Degeneration. Ferrara D; Seddon JM JAMA Ophthalmol; 2015 Jul; 133(7):785-91. PubMed ID: 25880396 [TBL] [Abstract][Full Text] [Related]
5. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials. Lin LY; Zhou Q; Hagstrom S; Maguire MG; Daniel E; Grunwald JE; Martin DF; Ying GS; JAMA Ophthalmol; 2018 Jun; 136(6):682-688. PubMed ID: 29801032 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of CC-cytokine ligand 2 and complementary factor H Y402H polymorphisms and their interactional association with age-related macular degeneration. Bonyadi M; Foruzandeh Z; Mohammadian T; Fotouhi N; Soheilian M; Jabbarpoor Bonyadi MH; Javadzadeh A; Moein H; Yaseri M Acta Ophthalmol; 2016 Dec; 94(8):e779-e785. PubMed ID: 27316788 [TBL] [Abstract][Full Text] [Related]
7. [Age-related Macular Degeneration in the Japanese]. Yoshimura N Nippon Ganka Gakkai Zasshi; 2016 Mar; 120(3):163-88; discussion 189. PubMed ID: 27164756 [TBL] [Abstract][Full Text] [Related]
8. Investigation of genetic base in the treatment of age-related macular degeneration. Gourgouli K; Gourgouli I; Tsaousis G; Spai S; Niskopoulou M; Efthimiopoulos S; Lamnissou K Int Ophthalmol; 2020 Apr; 40(4):985-997. PubMed ID: 31916060 [TBL] [Abstract][Full Text] [Related]
9. Genetic and clinical factors associated with reticular pseudodrusen in exudative age-related macular degeneration. Yoneyama S; Sakurada Y; Mabuchi F; Imasawa M; Sugiyama A; Kubota T; Iijima H Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1435-41. PubMed ID: 24595987 [TBL] [Abstract][Full Text] [Related]
10. Genes in the high-density lipoprotein metabolic pathway in age-related macular degeneration and polypoidal choroidal vasculopathy. Liu K; Chen LJ; Lai TY; Tam PO; Ho M; Chiang SW; Liu DT; Young AL; Yang Z; Pang CP Ophthalmology; 2014 Apr; 121(4):911-6. PubMed ID: 24393350 [TBL] [Abstract][Full Text] [Related]
11. Analysis of rare variants in the CFH gene in patients with the cuticular drusen subtype of age-related macular degeneration. Duvvari MR; Saksens NT; van de Ven JP; de Jong-Hesse Y; Schick T; Nillesen WM; Fauser S; Hoefsloot LH; Hoyng CB; de Jong EK; den Hollander AI Mol Vis; 2015; 21():285-92. PubMed ID: 25814826 [TBL] [Abstract][Full Text] [Related]
12. Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration. Nischler C; Oberkofler H; Ortner C; Paikl D; Riha W; Lang N; Patsch W; Egger SF Acta Ophthalmol; 2011 Jun; 89(4):e344-9. PubMed ID: 21232084 [TBL] [Abstract][Full Text] [Related]
13. Effects of aflibercept for ranibizumab-resistant neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Kawashima Y; Oishi A; Tsujikawa A; Yamashiro K; Miyake M; Ueda-Arakawa N; Yoshikawa M; Takahashi A; Yoshimura N Graefes Arch Clin Exp Ophthalmol; 2015 Sep; 253(9):1471-7. PubMed ID: 25391986 [TBL] [Abstract][Full Text] [Related]
14. Distribution of risk alleles in patients with age-related macular degeneration. Nielsen MK; Subhi Y; Molbech CR; Grønskov K; Sørensen TL Dan Med J; 2020 Mar; 67(3):. PubMed ID: 32138827 [TBL] [Abstract][Full Text] [Related]
15. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy. Jirarattanasopa P; Ooto S; Nakata I; Tsujikawa A; Yamashiro K; Oishi A; Yoshimura N Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3663-72. PubMed ID: 22570352 [TBL] [Abstract][Full Text] [Related]
16. Association study of complement factor H, C2, CFB, and C3 and age-related macular degeneration in a Han Chinese population. Liu X; Zhao P; Tang S; Lu F; Hu J; Lei C; Yang X; Lin Y; Ma S; Yang J; Zhang D; Shi Y; Li T; Chen Y; Fan Y; Yang Z Retina; 2010 Sep; 30(8):1177-84. PubMed ID: 20523265 [TBL] [Abstract][Full Text] [Related]
17. Genetic variants in the SKIV2L gene in exudative age-related macular degeneration in the Japanese population. Yoneyama S; Sakurada Y; Mabuchi F; Sugiyama A; Kubota T; Iijima H Ophthalmic Genet; 2014 Sep; 35(3):151-5. PubMed ID: 24865191 [TBL] [Abstract][Full Text] [Related]
18. FPR1 interacts with CFH, HTRA1 and smoking in exudative age-related macular degeneration and polypoidal choroidal vasculopathy. Liang XY; Chen LJ; Ng TK; Tuo J; Gao JL; Tam PO; Lai TY; Chan CC; Pang CP Eye (Lond); 2014 Dec; 28(12):1502-10. PubMed ID: 25277308 [TBL] [Abstract][Full Text] [Related]
19. Association of Smoking and CFH and ARMS2 Risk Variants With Younger Age at Onset of Neovascular Age-Related Macular Degeneration. Lechanteur YT; van de Camp PL; Smailhodzic D; van de Ven JP; Buitendijk GH; Klaver CC; Groenewoud JM; den Hollander AI; Hoyng CB; Klevering BJ JAMA Ophthalmol; 2015 May; 133(5):533-41. PubMed ID: 25695752 [TBL] [Abstract][Full Text] [Related]
20. Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration. Smailhodzic D; Muether PS; Chen J; Kwestro A; Zhang AY; Omar A; Van de Ven JP; Keunen JE; Kirchhof B; Hoyng CB; Klevering BJ; Koenekoop RK; Fauser S; den Hollander AI Ophthalmology; 2012 Nov; 119(11):2304-11. PubMed ID: 22840423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]